Abstract
A mass immunization campaign is a rapid vaccination intervention across age groups as opposed to provision through routine vaccination at a specified age attainment. Some countries use campaigns routinely as they have experience that shows that in their health systems higher coverage can be reached through campaigns than by routine service provision. Whilst many industrialized and non-industrialized countries have introduced new vaccines into their routine programme, the UK is unusual in deliberately doing this via campaigns. A number ofmass immunization campaigns have been implemented in the UK, either integrated into the routine immunization programme such as the annual influenza immunization campaign; as a catch-up campaign alongside the introduction of a new vaccine into the routine vaccination schedule (MMR, Haemophilus influenzae b, Meningococcal C conjugate vaccine); or as a one-off campaign, to boost immunity in a particular age group, without introducing the vaccination into the schedule routinely at that age (Haemophilus influenzae b). Campaigns require intense planning at national and local level with leadership to achieve propermanagement.Although the components of an immunization campaign can be described separately-strategic planning, vaccine supply, communication and surveillance; for a programme to be successful integrated planning is essential.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pan American Health Organization (http://www.paho.org)
Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C (1997) The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme, Commun Dis Rep CDR Rev 7(2):R26–R32
Gay N, Miller E, Hesketh L, Morgan-Capner P, Ramsay M, Cohen B, Brown D (1997) Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule. Commun Dis Rep CDR Rev 7(2):R21–R26
Trotter CL, Ramsay ME, Slack MP (2003) Rising incidence of Haemophilus in-fluenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. Commun Dis Public Health 6:55–58
Miller C, Miller E, Rowe K, Bowie C, Judd M, Walker D (1989) Surveillance of symptoms following MMR vaccine in children. Practitioner. 233:69–73
Yarwood J, Noakes K, Kennedy D, Campbell H, Salisbury D (2005) Tracking mothers attitudes to childhood immunisation 1991–2001. Vaccine 2005, in press
Keane V (1993) et al. Perceptions of vaccine efficacy, illness and health among inner city parents. Clinical Pediatrics 1993:2–7
Chen RT, Davis RL, Sheedy KM (2004) Safety of Immunizations. In: Plotkin SA, Orenstein WA (eds). Vaccines, 4th edn. W.B. Saunders Company, p1557
da Silveira CM, Kmetzsch CI, Mohrdieck R, Sperb AF, Prevots DR (2002) The risk of aseptic meningitis associatedwith the Leningrad-Zagrebmumps vaccine strain followingmass vaccination withmeasles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997. Int J Epidemiol 5:978–982
da Cunha SS, Rodrigues LC, Barreto ML, Dourado I (2002) Outbreak of aseptic meningitis and mumps after mass vaccination with MMR vaccine using the Leningrad-Zagreb mumps strain. Vaccine 20:1106–1112
HM Stationery Office, Chief Medical Officer, Annual Report, 1957
Miller C, Miller E, Rowe K, Bowie C, Judd M, Walker D (1989) Surveillance of symptoms following MMR vaccine in children. Practitioner. 233(1461):69–73
MMR Three way protection for your child, Question and Answer paper
HM Stationery Office, 1988
Ramsay M, Gay N, Miller E, Rush M, White J, Morgan-Capner P, Brown D (1994) The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev 11(4):R141–R146
Ramsay M, Gay N, Miller E, Rush M, White J, Morgan-Capner P, Brown D (1994) The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev 11(4):R141–R146
Carter H, Gorman D (1993) Measles outbreak in Fife: which MMR policy? Public Health 107:25–30
Progress toward interrupting indigenous measles transmission-Region of the Americas, January 1999–September 2000. MMWR Morb Mortal Wkly Rep 2000 3(49):986–990
Medicines Control Agency (1995) Adverse reactions to measles and rubella vaccine. 21:9–10
Trotter CL, Ramsay ME, Slack MP (2003) Rising incidence of Haemophilus in-fluenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign. Commun Dis Public Health 6:55–58
http://www.dh.gov.uk/assetRoot/04/11/40/18/04114018.pdf
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Noakes, K., Salisbury, D. (2006). Immunization Campaigns in the UK. In: Plotkin, S.A. (eds) Mass Vaccination: Global Aspects — Progress and Obstacles. Current Topics in Microbiology and Immunology, vol 304. Springer, Berlin, Heidelberg . https://doi.org/10.1007/3-540-36583-4_4
Download citation
DOI: https://doi.org/10.1007/3-540-36583-4_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29382-8
Online ISBN: 978-3-540-36583-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)